Quantcast

Latest Heparin Stories

2009-08-31 07:30:00

BASKING RIDGE, N.J., Aug. 31 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the results of a Phase 2a clinical trial of their lead product, the anticoagulant system REG1, were released at the European Society of Cardiology Congress in Barcelona, Spain. The results, detailed in a poster entitled, "First Clinical Application of an Actively Reversible Direct Acting Factor IXa...

816f219bcafd396350cebc9464e36e431
2009-08-24 11:40:00

"Thick" blood can cause heart attack and stroke, but also prevent them. Scientists at Heidelberg University Hospital have explained the mechanism of this clinical paradox for the first time on an animal model. Mice with a greater tendency to form blood clots have larger plaques in their vessels, but they are more stable. Thus, there is less risk that these plaques will rupture and obstruct circulation. The results of the study have been published in the prestigious journal...

2009-08-17 08:00:00

BOZEN, Italy, August 17 /PRNewswire/ -- Health Robotics today announced that it has reached an agreement with Gregorio Maranon Foundation to sell and install its revolutionary i.v.STATION robot at the GMU Hospital this October, concurrent with the nine American i.v.STATION installations at Duke University, MD Anderson Cancer Center, Brigham & Women's, Univ. of Pennsylvania, Univ. of Southern California, Fairview-University of Minnesota, Ochsner Clinic, Allegiance Health, and Univ. of...

2009-08-17 07:53:00

BRIDGEWATER, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. (EURONEXT: SAN and NYSE: SNY) announced today results of a retrospective real-world cohort study comparing the total direct medical costs of Lovenox(R) (enoxaparin sodium injection) or unfractionated heparin (UFH) for the prevention of venous thromboembolism (VTE) among at-risk hospitalized medical and surgical patients in the U.S. The study demonstrated VTE prophylaxis with enoxaparin was a cost-saving therapy with...

2009-08-12 08:51:00

OCEAN, N.J., Aug. 12 /PRNewswire/ -- QualTech Laboratories, Inc., an analytical testing laboratory specializing in biological assays, toxicity studies, and quality control measures, announced today that they have validated the USP (United States Pharmacopeia) method for the anti-factor IIa chromogenic assay for potency. This anti-factor IIa assay is a required component of the newly-revised Heparin Sodium monograph, which becomes effective October 1, 2009. The Heparin Sodium monograph...

2009-07-30 12:15:00

International workshop assesses revisions aimed at the purity, quality of blood thinnerContinuing to help ensure the identity, purity and quality of heparin, the U.S. Pharmacopeial (USP) Convention has revised written and physical standards for the widely used blood thinner. In February, USP released updated heparin standards at the request of the Food and Drug Administration (FDA) in response to the 2008 public health crisis in which more than 200 people died as a result of heparin...

d4698206d592c296b8e68eb2d466f1cb1
2009-07-29 11:25:00

Scientists in New York and North Carolina are reporting assembly of the first functioning prototype of an artificial Golgi organelle. That key structure inside cells helps process and package hormones, enzymes, and other substances that allow the body to function normally. The lab-on-a-chip device could lead to a faster and safer method for producing heparin, the widely used anticoagulant or blood thinner, the researchers note. Their study is scheduled for the Aug. 12 issue of the Journal of...

2009-06-15 07:30:00

- Ready-to-use, Chromogenic Assay for Monitoring UF and LMW Heparin - BEDFORD, Mass., June 15 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its HemosIL Liquid Heparin assay. Previously, the Company received a license for the product from Health Canada, as well as a European CE IVD Mark. With this latest clearance in the US, the company can now initiate commercialization in North...

2009-05-19 06:00:00

MOUNTAIN VIEW, Calif., May 19 /PRNewswire/ -- Cardiva Medical, Inc. announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) for its latest technology, the Cardiva Catalyst III, which is considered the first drug coated vessel closure device in the market. Built upon its predecessor, the Catalyst III is coated with protamine sulfate, a drug which neutralizes heparin in the tissue adjacent to the device. Local heparin reversal by the Catalyst III...

2009-05-12 15:34:29

U.S. health officials are investigating whether the blood thinner heparin is linked to two patient deaths, the product's maker says. Baxter International Inc. of Deerfield, Ill., said Tuesday the U.S. Food and Drug Administration and a Delaware hospital were looking into whether medical providers were using heparin contained in intravenous bags when the patients died, The Chicago Tribune reported. The use of heparin has been suspended at Beebe Medical Center in Lewes, Del., Friday, where five...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related